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Cost-effectiveness of percutaneous fixation with Kirschner wires versus 
locking-plate for adult patients with a dorsally displaced fracture of the distal 
radius from the DRAFFT trial 
 
Abstract 
 
We present the economic evaluation from the Distal Radius Acute Fracture Fixation Trial, which 
compared the cost-effectiveness of K-wire fixation with locking-plate fixation for patients with a 
dorsally-displaced fracture of the distal radius. 
The cost-effectiveness analysis (cost per QALY) was derived from a multi-centre, two-arm, 
parallel group, assessor-blind randomised controlled trial which took place in 18 trauma centres 
in the UK. Resource use data were received from 460 patients; only one patient did not provide 
any resource use data. The analysis includes both the Health Service perspective ± cost of 
surgery, implants, physiotherapy etc ± and the societal perspective - cost of time off work and 
private care.  
There was small difference in health-related quality of life (QALYs gain) for patients treated 
with locking-plate versus K-wire fixation. At an additional cost of £714, locking-plate fixation 
presented an incremental cost-effectiveness ratio of £89,322 per QALY within the first 12 
months of treatment. A number of sensitivity analyses were undertaken, but the incremental cost-
effectiveness ratios of locking-plates fixation compared with K-wires were always more than 
£30,000. 
The economic evaluation is driven by the choice of fixation; K-ZLUHIL[DWLRQLVD µFRVWVDYLQJ¶
intervention being substantially less expensive than locking-plate fixation. 
 
Key words: cost-effectiveness ± distal radius fractures ± fixation ± K-wire ± QALY ± volar 
locking-plate ± within-trial   
JEL classification: D04 - D69 - I18  
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1 Introduction 
Fractures of the distal radius are extremely common injuries; they are treated non-operatively if 
the bone fragments can be held in anatomical alignment by a plaster cast or orthotic. However, if 
this is not possible then surgical fixation is required. Surgery may provide functional benefits, 
but carries a risk of complications for the patients and considerable expense for the healthcare 
system; much of that expense is related to the choice of fixation.  
The two most common forms of surgical treatment for dorsally displaced fractures are K-wire 
fixation and locking-plate fixation. In the last five years, there has been a rapid rise in the use of 
locking-plates despite the additional cost of the implants (Mellstrand-Navarro et al., 2014). This 
change in practice was predominantly based upon the results of single-centre trials which 
suggested that locking-plates provide improved radiological and/or functional outcomes 
(Karantana et al., 2013, Downing and Karantana, 2008, Rozental et al., 2009, Marcheix et al., 
2010a, McFadyen et al., 2011, Hollevoet et al., 2011, Marcheix et al., 2010b).  
We present the health economic evaluation from a multi-centre randomised controlled trial of K-
wire fixation versus locking-plate fixation in the treatment of adult patients with a dorsally 
displaced fracture of the distal radius; UK DRAFFT. 
 
2 Patients and methods 
Intervention and sample 
Patients were eligible for the trial if they were 18 years or over, with a dorsally displaced 
fracture of the distal radius, within 3 cm of the radio-carpal joint. The only other inclusion 
criterion was that the treating surgeon believed that the patient would benefit from surgical 
fixation of the fracture. Further details of the protocol are reported elsewhere (Costa et al., 
2011). The primary outcome measure was the Patient Rated Wrist Evaluation (PRWE) 
(MacDermid et al., 1998). The clinical analysis concluded that this trial showed no difference in 
functional outcome between K-wires and volar locking-plates for patients with dorsally 
displaced fractures of the distal radius (Costa et al., 2014). 
19 
 
Perspective 
We assessed the cost-effectiveness of locking-plate fixation versus K-wire fixation for the 
treatment of distal radial fractures from the NHS perspective and from a societal perspective. 
The NHS perspective considers only resources used within the NHS setting; the societal 
perspective additionally considers private costs including time-off work due to the treatment. All 
costs were adjusted to 2012 prices using the CCEMG-EPPI Centre Cost Converter (CCEMG-
EPPI, 2013). The analysis uses the within-trial period (twelve months following the injury), 
discounting for the future cost and health outcome was not necessary. The currency used was the 
pound sterling (£). 
Quality of life 
3DWLHQW¶VKHDOWK-related quality of life was assessed using the EQ-5D-3L questionnaire (Brooks 
et al., 2005) pre-injury, at baseline, 3, 6 and 12 months. Changes in EQ-5D scores were 
evaluated using two-sample t-tests to explore any important differences in the follow-up points 
within the time frame of the trial. In line with the NICE reference case (NICE, 2008) the primary 
outcome for the economic evaluation was quality-adjusted life years (QALYs). Patient responses 
to the EQ-5D questionnaire at each time point were converted to QALYs using the standard UK 
tariff values (Dolan, 1997) DQG³DQDUHDXQGHU WKHFXUYHDSSURDFK´$YHUDJH4$/<VEHWZHHQ
adjacent time points were calculated to generate smoothed estimates between those time points.  
Resource use and valuation 
The total cost of each arm of the trial was calculated combining the reported resource usage over 
the 12 month follow up and unit cost data along with the initial surgery cost.  
Patients reported resource usage within the trial at 3, 6 and 12 months. For the 3 month data, the 
recall period was since discharge from hospital. For the other cases, it was since the last 
questionnaire was due to be completed. The questionnaires included number of further inpatient 
stays following the initial operation; number of outpatient, primary and community care visits, 
use of aids and adaptations and medication use. Patients also reported use of personal social 
services related to their treatment including number of weeks of frozen/hot meals on wheels, and 
laundry services.  
Resource usage figures were converted into costs using unit cost figures from the PSSRU Costs 
of Health and Social Care 2012 (Curtis, 2012) DQGWKH'HSDUWPHQWRI+HDOWK¶V5HIHUHQFH&RVWV
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(Department of Health, 2013). In Appendix, Table A1 presents the summary of health care use 
collected and associated unit costs.  
Further inpatient care following the initial operation was costed as Minimal Elbow and Lower 
Arm Procedures for Non-Trauma except if surgical hand complications like metal removal or 
debridement were reported at 6-week follow-up, where inpatient stay was costed for Trauma.  
Unit costs for medications were obtained from the British National Formulary ((BNF), 2013) 
and the NHS Electronic Drug Tariff (Wales, 2013). Patients reported details for medications that 
were taken within the three budgetary periods (discharge to 3 months, 3-6 months, and 6-12 
months). Total medication costs were then calculated using the average cost per dose for each 
product. Table A2 shows all the unit costs for the drugs that were reported in the trial. 
Unit costs for aids and adaptations were taken from the website http://www.mobilitysmart.cc/, 
which supplies the NHS. Patients reported any equipment that they had used to protect their 
injury or make their daily life easier to manage. Reported aids and adaptations and unit prices 
are available in Table A3. 
The initial fixation surgery cost was based on the initial hospital stay and the operative cost. The 
cost of the initial distal radial fracture fixation surgery was assessed using NHS reference costs 
and HRG cost for Minor Elbow and Lower Arm Procedures for Trauma. Costs for the initial 
operative period were identified for each patient using the average length of stay as reported in 
the patient records for the primary surgery. They were assumed to be £1,375.34 for a day case or 
£1,983.39 for overnight admission. Excess bed day costs were used when patient experienced a 
length of stay beyond the average reported length of stay. For example, the cost to NHS was 
£1,375.34 if a patient was discharged the same day, £1,983.39 if the patient was referred to 
overnight hospital care at least one night but no more than the average length of stay; extra bed 
day costs (based on a bed day cost of £278.07) were added if a patient stayed more than the 
average length of stay. This cost was taken to include all expenditures incurred prior to 
discharge, including any items provided to patients before departure. The operative costs for 
both locking plate and K-wire fixations were provided by the University Hospitals of Coventry 
and Warwickshire (UHCW) finance department, these included implant costs and consumables 
and are reported in Table A4. 
Productivity and private costs 
Cost from the societal perspective were calculated by combining loss of earnings due to work 
absence, private costs such as treatments within private settings and out-of-pocket expenses 
incurred as a result of the wrist surgery, and reported use of personal social services related to the 
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treatment. Personal social services included number of weeks of frozen/hot meals on wheels, 
laundry services, and number of visits of carers and social workers. Unit costs were assigned 
using PSSRU and information from Centres of Personal Social Services; they are reported in 
Table A5.  
Patients reported their time off work in days or in terms of lost income at every collection point. 
A human capital approach was used to generate the cost of lost productivity per day using the 
gross median weekly pay rate for full-time employees from the Office for National Statistics 
(£506, April 2012) divided by five. 
Missing data 
The mean total costs per patient from a NHS perspective was calculated adding the cost of 
inpatient stay, outpatient visit, consultations, medication, equipment, and intervention costs for 
all patients where response data were available. Respondents who failed to complete individual 
items of the EQ-5D were not allocated a utility index score. From the overall sample, missing 
data represented 7.07%. The complete data analysis was based on 278 patients. For those cases 
in which either resource usage or quality of life data was unavailable, we addressed missingness 
using multiple imputations via chained equations (Little and Rubin, 2002) assuming missing at 
random and using STATA 12. Missing cost data were predicted in terms of QALYs, treatment 
UHFHLYHG OHQJWK RI VWD\ DJH JHQGHU MRE VWDWXV SDWLHQW¶V VHOI-reported health status, PRWE 
score, and Disability of the Arm, Shoulder and Hand score. Missing QALYs data were predicted 
in terms of this same list (excluding QALYs), plus each of the cost items. In order to remove 
implausible data, missing cost data were constrained to be positive. A total of 10 imputations 
were created to stabilise the results. The reported cost-effectiveness results were synthesized 
based on all imputed datasets. 
Cost-effectiveness analysis 
The within-trial analysis aimed to determine the intervention that would maximise health 
outcomes within (1) the limited NHS budget and (2) within a societal perspective over the 12-
month trial follow up. It adopted an intention-to-treat perspective and consisted in a cost-utility 
analysis examining the cost per QALY gained for all patients. Descriptive statistics of costs and 
EQ-5D scores were initially undertaken and parametric tests conducted to evaluate any 
important differences in the end points within the time frame of the trial. Incremental cost-
effectiveness ratios (ICER) were then calculated dividing the average difference in cost between 
the two arms by the average difference in QALYs between the two arms. 
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The ICER represents the additional cost per one unit of outcome gained. This indicates the trade-
off between total costs and effectiveness when choosing between volar locking-plate fixation 
and K-wire fixation. When compared against the marginal trade-off for the NHS as a whole this 
gives an indication of whether spending additional money on volar locking-plate fixation 
appears efficient. As a guideline rule, the National Institute for Health and Care Excellence 
considers as cost-effective an intervention with an ICER of less than £20,000 per QALY and 
generally states that an intervention costing more than £30,000 per QALY is not considered 
cost-effective.  
The nonparametric bootstrapping approach with replacement was used to determine the level of 
sampling uncertainty around the ICER; the bootstrap consists in resampling from the original 
sample to create multiple random samples and generate 10,000 estimates of incremental costs 
and benefits. The uncertainty in the ICER was presented using cost-effectiveness acceptability 
curves (CEACs) illustrating the probability that each treatment is cost-effective in relation to the 
comparative intervention, as a function of the willingness-to-pay (Ramsay et al., 2001).  
A number of univariate sensitivity analyses were conducted. To evaluate the impact of missing 
data, a complete case analysis was conducted where only those participants with no missing data 
were analysed. We then separated the analysis according to age (above or below 50 years) as age 
was used as a stratification factor in the trial to balance differences in bone density between 
younger and older patients; the two age groups are assumed to present different types of 
fractures (high and low energy fractures) and so the impact of the fixation was expected to differ 
by age. Finally, adjusted cost-effectiveness analyses were also undertaken using baseline 
covariates including age, gender, and EQ-5D scores. 
3 Results 
Trial recruitment 
From January 2011 through July 2012, 461 patients were randomised (K-wire=230; locking-
plate=231). One patient in the locking-plate arm of the study did not provide any quality of life 
data and so was excluded from the analysis.  
Quality of life 
Table 1 details the EQ-5D scores at pre-injury, baseline, 3, 6 and 12 months when missing 
values were imputed. Both groups showed increasing EQ-5D scores from baseline to the last 
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follow-up point. The most important increase was observed between baseline and 3 month; 
doubling the baseline EQ-5D score in both arms. It was noted that patients at 12 months had not 
recovered an EQ-5D score equivalent to their pre-injury EQ-5D score. The average total QALYs 
over the 12 months was marginally higher in the locking-plate arm (0.742) than in the K-wire 
arm (0.734). There were no significant differences between EQ-5D scores at baseline for the two 
treatment arms. 
Health care resource usage  
Resource use was broadly comparable between the two treatments (Table A6). Patients were 
frequent users of physiotherapy outpatient visits (6.9 visits over the 12 months) and reported on 
average 3.6 visits in radiology and 3.6 visits in orthopaedics. Visits to the GP and nurses were 
infrequent. Patients reported using a wrist brace or splint. In terms of medications, we noted that 
paracetamol tablets were the most reported medications in the questionnaire.  
Costs 
The mean total NHS resource use costs were respectively £3,385 for K-wires and £4,288 for 
volar locking-plate and were significantly higher for volar locking-plate (+£903) (Table 2). Lost 
earnings and productivity losses to employers through sickness absences appeared higher in the 
K-wire arm, but the difference was not significant. Overall societal costs were on average £48 
higher in the K-wire arm.  
Cost-effectiveness and sensitivity analyses 
The results suggested that volar locking-plate was more expensive than K-wires with an 
incremental cost of £726.46 and had higher, albeit small, QALY gains. Differences in QALY 
gains were 0.008 QALYs (which is equivalent to an extra three days of perfect health per year) 
between groups. We graphically represented the uncertainty of these estimates; Figure 1 showed 
that all the points were above the x-axis, indicating that the volar locking-plate was more costly, 
and more points were to the right of the y-axis, indicating that volar locking-plate produced more 
QALYs. The points in the plane lay in the area e where there is a trade-off between effect and 
cost: additional health benefit can be obtained but at higher cost. The ICER of locking-plate 
versus K-wires equalled £89,322 per QALY and under these circumstances, locking-plate could 
not be considered cost-effective as its ICER was above the NICE £20k-£30k per QALY range. 
The CEAC is presented in Figure 2 with a range of willingness-to-pay (WTP) thresholds values. 
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The probability of locking-plate fixation to be cost-effective was very low; at a WTP threshold 
of £20,000 per QALYs it was nil and only raised to 3% at a threshold of £30,000. 
Within most of the sensitivity analyses undertaken here, the ICER appeared to remain above the 
£20k-£30k per QALY range (Table 3) even with the adjusted analysis that showed a lower 
incremental cost for a similar incremental QALYs gain both in the NHS and the societal 
perspectives. In the sample of patients aged more than 50, the evaluation suggested that patients 
who were treated with a locking-plate fixation gained 0.018 QALYs more than those treated 
with a K-wire fixation at an increased cost of £629 per patient, yielding an incremental cost-
effectiveness ratio of £35,323 per QALY. In the sample of patients aged less than 50, locking-
plate fixation was associated with lower benefits and higher costs than K-wires fixation, and so 
locking-plate fixation appeared to be dominated for this subgroup of individuals.  
4 Discussion 
In comparison with K-wires, locking-plate fixation did not show clinically relevant differences 
in QALY gain within the first 12 months from surgery. However, locking-plate fixation did 
present greater costs; these were largely driven by the higher cost of the initial surgery (£818.26 
vs. £54.23). This incremental cost was not offset against a decrease in health care resource use or 
savings in lost productivity during the 12 months follow-up after discharge. The incremental cost 
of locking-plate fixation from an NHS perspective was £726 and £581 from a societal 
perspective. 
The base-case analysis found an incremental QALY gain to favour locking-plate fixation but the 
difference was very small 0.008 (95% CI: -0.001 to 0.018) and the confidence intervals excluded 
QALY gain values whereby locking-plates would be a cost-effective intervention. A back-of-
the-envelope-calculation yields that a net QALY gain of at least 0.036 would be required for the 
incremental cost of £726 to provide cost-effectiveness at a willingness-to-pay of £30,000 per 
QALY. The locking-plates would have had to provide very much greater QALY gains for the 
NHS to consider paying the extra cost of the implants. The high ICER and the low probability of 
locking-plate fixation to be cost-effective for a £20k-£30k willingness-to-pay threshold 
demonstrated that locking-plate fixation is not cost-effective. This result is robust to sensitivity 
analysis and stochastic bootstrapping. 
The results showed that EQ-5D score was a suitable measure of health utility for this population 
and was sensitive to distal radius fracture and fixation as there were important changes in the 
score values over the follow-up points. Previous cost analyses have focused on comparing the 
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cost of surgical fixation versus non-surgical treatment (Shauver et al., 2011a, Shauver et al., 
2011b, Papaloizos et al., 2004, Schonnemann et al., 2011, Davis et al., 2006, Vinnars et al., 
2007, Arora et al., 2007), they concluded that surgery had a higher initial cost, and could induce 
costs in relation to post-surgery complications. However, few studies have provided a 
comparative cost analysis of different types of surgical fixation. Shyamalan et al. (Shyamalan et 
al., 2009) retrospectively undertook a micro-costing analysis of percutaneous K-wire fixation for 
a distal radial fracture and locked volar-plate fixation for a sample of 10 patients for each 
treatment. They found a difference of £1,549 and 65 min theatre time between performing a 
percutaneous K-wire fixation procedure and a volar locked-plate procedure. The choice of 
implants also appeared to influence the overall cost considerably (Horriat and Marsh, 2011, 
Kakarlapudi et al., 2000). However, in the absence of randomised control trials comparing 
surgical options for the management of distal radial fractures, the cost-effectiveness of distal 
fracture fixations had never been fully explored. This is a particularly pertinent issue, since the 
current trend in surgical practice is towards the increasing use of the more expensive locking-
plate fixation. 
 
The main limitation of the trial is that it was not possible to blind either the surgeons or the 
patients to the study WUHDWPHQWV ,W LV LPSRUWDQW WRXQGHUOLQHWKDWZHXVHGKHUHD µFRQVHUYDWLYH¶
estimate of the cost of initial surgery: this did not take into account the extra theatre operating 
time required for the locking-plate fixation: 31 min for wires and 66 min for plates. It is likely 
that a micro-costing analysis of the initial surgery in each arm could lead to even higher costs 
differences.  
 
In conclusion, K-ZLUHIL[DWLRQLVDµFRVWVDYLQJ¶LQWHUYHQWLRQEHLQJVXEVWDQWLDOO\OHVVH[SHQVLYH
than locking-plate fixation and locking-plates fixation showing minimal difference in health 
benefits. 
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6 Tables and figures  
Table 1 ± Mean EQ-5D index scores at the baseline and follow-ups and annual QALYs of distal 
fracture fixation by treatment arms 
 
 
K-Wire 
n = 141 
Locking-plate 
n=137 Difference 
Mean (SD) Mean (SD) P-value of t-test 
Retrospective pre-injury  0.928 (0.170) 0.947 (0.149) 0.320 
Baseline  0.354 (0.303) 0.373 (0.317) 0.611 
3 months  0.725 (0.210) 0.739 (0.224) 0.591 
6 months  0.787 (0.193) 0.807 (0.183) 0.366 
12 months  0.842 (0.188) 0.845 (0.184) 0.918 
 Mean (SD) Mean (SD) Difference (95% CI) 
Total QALYs (non-
imputed) 0.734 (0.166) 0.742 (0.159) 0.008 (-0.001, 0.018) 
Total QALYs (imputed) 0.734 (0.167) 0.744 (0.156) 0.010 (0.001, 0.019) 
 
Table 2 ± Costs of resources used in relation to distal fracture fixation by treatment arms  
 
 
K-Wire 
n = 230 
Locking-plate 
n=230 
Difference 
 
Mean (SD) Mean (SD) P-value of t-test 
NHS resource use costs* £1524.84 (1840.14) £1590.19 (2216.07) 0.789 
Social care costs £13.01 (105.37) £8.18 (57.97) 0.637 
Private cost £9.74 (66.51) £22.05 (149.05) 0.372 
Cost of lost productivity £394.26 (1704.29) £249.16 (1128.92) 0.405 
 Mean (SD) Mean (SD) 
Difference (95% 
CI) 
Total costs (NHS PSS perspective)** £3440 (2539) £4154 (2203) £714 (588, 864) 
Total costs (Societal perspective)** £3832 (3142) £4413 (2927) £581 (401, 761) 
*The costs do not include the cost of the initial operation/care.   
**The costs include the cost of the initial operation/care.  
 
Table 3 ± Incremental cost-effectiveness 
 
Scenario Incremental costs Incremental QALYs ICER  
(Cost per QALY) 
Base case (imputed, NHS PSS perspective) £714 (588, 864) 0.008 (-0.001, 0.018) £89,322 
Complete case (NHS PSS perspective) £903 (392, 1414) 0.014 (-0.025, 0.053) £64,026 
Above 50 years old (NHS PSS perspective) £629 (412, 846) 0.018 (0.007, 0.029) £35,323 
Below 50 years old (NHS PSS perspective) £446 (172, 720) -0.013 (-0.028, 0.003) K-wires dominates 
Base case (imputed, societal perspective) £581 (401, 761) 0.010 (0.001, 0.019) £58,852 
Complete case (societal perspective) £791 (60, 1521) 0.014 (-0.025, 0.053) £56,020 
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Figure 1 ± Cost-effectiveness plane generated from bootstrapped mean cost and QALYs 
differences over 12 months (NHS perspective, all patients) 
 
 
 
Figure 2 ± Cost-effectiveness acceptability curves at 12 months (NHS perspective, all patients) 
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Appendix 
Table A1 ± Summary of patient-reported health care use and associated unit costs 
Item Unit cost (£) Source 
Subsequent Inpatient Care 
Inpatient (orthopaedics ± wrist/arm) 
Cost for average LOS £2064.71 National schedule of reference costs year 2011-2012 - 
Day case £692.04 National schedule of reference costs year 2011-2012 - 
Adjustment per day ± av. LOS £302.01 National schedule of reference costs year 2011-2012 - 
Inpatient (orthopaedics ± other bones) 
Cost for average LOS £3556.04 National schedule of reference costs year 2011-2012 - 
Day case £928.36 National schedule of reference costs year 2011-2012 - 
Adjustment per day ± av. LOS £293.08 National schedule of reference costs year 2011-2012 - 
Inpatient (other non-surgery)  
Cost for average LOS £2688.10 National schedule of reference costs year 2011-2012 - 
Day case £602.61 National schedule of reference costs year 2011-2012 - 
Adjustment per day ± av. LOS £261.21 National schedule of reference costs year 2011-2012 - 
Inpatient (other)   
Rehabilitation unit £985.00 PSSRU 2012, p.114, weekly service costs per bed 
Outpatient care 
Orthopaedics £103.72 National schedule of reference costs year 2011-2012 - 
Pathology £60.74 National schedule of reference costs year 2011-2012 - 
Radiology £153.21 National schedule of reference costs year 2011-2012 - 
Physiotherapy £40.70 National schedule of reference costs year 2011-2012 - 
Primary and community care 
GP surgery visit £40.00 PSSRU2012, p.182-3, £3.40 per min, average 11.7 min 
GP clinic visit £58.00 PSSRU2012, p.182-3, £4.3 per min, 17.2 mins per visit 
GP home visit £101.00 PSSRU2012, p.182-3, £258 per hour, average 23.4 min 
GP phone contact £24.00 PSSRU2012, p.182-3, 7.1 min contact 
Practice nurse surgery visit £11.63 PSSRU2012, p.180-1, £45 per hour, average 15.5 min 
Practice nurse home visit  £18.75 PSSRU2012, p.180-1, £45 per hour, average 25 min visit 
Practice nurse phone contact £3.50 PSSRU2012, p.180-1, £35 per hour, average 6 min visit 
District nurse surgery visit £10.85 PSSRU2012, p.175, £42 per hour, average 15.5 min visit 
District nurse home visit £21.83 PSSRU2012, p.175, £61 per hour, average 20 min visit 
District nurse phone contact £4.2 PSSRU2012, p.175, £42 per hour , average 6 min visit 
Physiotherapist surgery visit £15.00 PSSRU2012, p.167, £30 per hour, average 30 min per 
Physiotherapist home visit £44.16 PSSRU2010, p.151, £39 per hour, average 60 min, 
Occupational therapist surgery visit £15.00 PSSRU2012, p.167, £30 per hour , average 30 min per 
Occupational therapist home visit £44.16 PSSRU2010, p.151, £39 per hour, average 60 min visit 
 
Table A2 ± Summary of patient-reported medication use and associated unit costs 
Item Unit cost (£) Source 
ADCAL £7.25 (from pack of 100) 
ADCAL-D3 £3.84 1500 mg (from pack of 56) 
Acupan £10.54 30 mg(from pack of 90) 
Adalat (Nifedipine) £7.23 5 mg (from pack of 84)  
Alendronic Acid £1.10 70 mg(from pack of 4) 
Alendronic Acid £1.44 10 mg(from pack of 28) 
Amoxicillin  £0.95 250 mg(from pack of 21) 
Amitriptyline £0.84 10 mg(from pack of 28) 
Amitriptyline £0.83 25 mg(from pack of 28) 
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Item Unit cost (£) Source 
Aspirin £0.76 75 mg(from pack of 28) 
Atenolol £0.83 100 mg (from pack of 28) 
Atorvastatin £1.89 10 ml (from pack of 28) 
Bendroflumethiazide £0.81 2.5 mg (from pack of 1) 
Benlafaxine £2.62 37.5 mg (from pack of 56) 
Bisoprolol £1.02 5 mg (from pack of 28) 
Cacit £11.81 (from pack of 76) 
Calceos £3.62 (from pack of60) 
Calcichew £4.24 (from pack of 60) 
Calcium Carbonate chewable £9.33 (from pack of 100) 
Calfovit D3 £4.32 (from pack of30) 
Citalopram £1.31 10 mg (from pack of 28) 
Clarithramycin £2.52 250 mg (from pack of14) 
Co-Amoxiclan £2.34 250 mg (from pack ) 
Co-codamol (tablet) £3.54 30 mg (from pack of100) 
Codeine (tablet) £2.26 30 mg (from pack of 30) 
Co-Dyramol £1.06 500 mg (from pack of 30) 
Diclofenac £1.42 50 mg (from pack of84) 
Dihydrocodeine £5.18 60 mg (from pack of 56) 
Emulgel £1.55 (from pack of 20) 
Enalapril Maleate £0.95 10 mg (from pack of 28) 
Ergocalciferol £30.34 1.25 mg (from pack of 50,000) 
Eye Drops £2.80 (from pack of 10) 
Ferrous Sulphate £1.01 (from pack of 28) 
Floxacillin £1.77 250 mg (from pack of 1) 
Flucloxacillin £2.89 500 mg (from pack of 28) 
Fultium £8.44 (from pack of 84) 
Furosemide £0.80 20 mg (from pack of 28) 
Ibruprofen  £1.44 200 mg (from pack of 84) 
Ibruprofen £1.73 400 mg (from pack of 84) 
Ibuprofen (gel)  £2.13 50 g (from pack of 1) 
Lansoprazol £1.20 15 mg (from pack of 28) 
Lercanidipine  £4.98 10 mg (from pack of 28) 
Livial Tibolone £10.36 2.5 mg (from pack of 28) 
Meloxicam £1.54 15 mg (from pack of 30) 
Meptid £22.11 200 mg (from pack of 112) 
Mirtazapine £3.08 15 mg (from pack of 28) 
Morphine £11.21 10 mg (from pack of 1) 
Naproxen  £1.25 250 mg (from pack of 28) 
Naproxen  £1.65 500 mg (from pack of 28) 
Nefopam £10.54 30 mg (from pack of 90) 
Nextum £25.19 40 mg (from pack of 28) 
Olanzapine £1.17 2.5 mg (from pack of 28) 
Omeprazole £1.62 20 mg (from pack of 28) 
Oramorph £1.78 10 mg (from pack of 100) 
Oxycodone £8.70 5 ml (from pack of 50) 
Oxycontin £49.82 20 mg (from pack of 56) 
Oxycontin £74.81 30 mg (from pack of 56) 
Paracetamol (tab) £0.16 500 mg (from pack of 16) 
Polyfax £3.26 4 g (from pack of 1) 
Pregabalin £2.77 400 mg (from pack of 84) 
Protelos £25.60 2 g (from pack of 28) 
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Item Unit cost (£) Source 
Risedeonate £19.12 35 mg (from pack of 4) 
Romipril (cap) £1.39 10 mg (from pack of 28) 
Solphadol £6.74 (from pack of 100) 
Tomoxifen  £5.71 10 mg (from pack of 30) 
Tramadol £1.14 50 mg (from pack of 30) 
Voltrrol  £3.46 25 mg (from pack of 30) 
Zopiclone £1.30 (from pack of 28) 
 
Table A3 ± Summary of patient-reported aids and adaptation equipment use, personal social 
services and associated unit costs 
 
Item Unit cost 
(£) 
Source 
Aids and adaptation   
Wrist brace/splint £10.00 MobilitySmart  
Grab rail £95.00 PSSRU2012, p.111, average 
Dressing aids £5.95 MobilitySmart  
Long-handle shoe horns £3.98 MobilitySmart  
Bathing aids £23.35 MobilitySmart  
Kitchen aids (jar/tin openers, etc) £21.44 MobilitySmart  
Personal social services   
Frozen meals on wheels (weekly) £41.40 Lewisham council, adult social 
Hot meals on wheels (weekly) £46.00 PSSRU2012 - p125 
Laundry services (per load) £4.30 North Yorkshire social care 
Care workers/Help at home (per £18.00 PSSRU2012, p.193 per weekday 
Social workers (per visit) £39.00 PSSRU2012, p.190 per hour 
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Table A4 ± Summary of the initial surgery theatre cost including consumables & prosthetic 
devices 
Description of item Code of Item Quantity used 
Unit 
Price Cost £ 
K-wire 
Reinforced gown XL 95224 2 3.74 7.48 
Surgical Visor Masks 48247 2 1.01 2.03 
Theatre Masks 48100 2 0.06 0.11 
Gammex gloves 351143 1 0.68 0.68 
Biogel gloves 96180 2 1.14 2.28 
Non-sterile gloves 8801 5 0.02 0.11 
Image Intensifier Cover 39.00.02 3 2.49 7.47 
Laceration Pack RMT9150 1 13.24 13.24 
Surface Wipes CMW01X 6 0.03 0.18 
Black Bag 
 
1 0.06 0.06 
Yellow Bag UN3291 2 0.05 0.11 
Polythene Bag for Extras  1 0.02 0.02 
Inco Pad 200995 2 0.13 0.26 
K wire OS292160 3 2.94 8.82 
Sterilation of Drill TSU 1 10.00 10.00 
Ethicon sutures w319 1 1.22 1.22 
Mepore 9*10cm r33334 1 0.16 0.16 
Total for equipment used for K-wire surgery 54.23 
Locking-plate 
Surgical Visor Masks 48247 3 1.01 3.04 
Theatre Masks 48100 2 0.06 0.11 
Gammex gloves 351143 1 0.68 0.68 
Biogel gloves 96180 3 1.14 3.42 
Non-sterile gloves 8801 6 0.02 0.14 
Image Intensifier Cover 39.00.02 3 2.49 7.47 
Upper Limb Pack RMT9150 1 12.40 12.40 
Surface Wipes CMW01X 6 0.03 0.18 
Black Bag  1 0.06 0.06 
Yellow Bag UN3291 2 0.05 0.11 
Polythene Bag for Extras  1 0.02 0.02 
Inco Pad 200995 2 0.13 0.26 
DVR Plate DVRAW(L/R) 1 384.00 384.00 
Shaft Screws CS(14) 3 27.00 81.00 
Bar Screws FP(12) 6 44.00 264.00 
Sterilation of Drill TSU 1 10.00 10.00 
Ethicon sutures w319 1 1.22 1.22 
Mepore 9*10cm r33334 1 0.16 0.16 
Sterilisation of basic set TSU 1 20.00 20.00 
Sterilisation of drill TSU 1 10.00 10.00 
Sterilisation of DVR set TSU 1 20.00 20.00 
Total for equipment used for locking-plate surgery 818.26 
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Table A5 ± Use of health care resources related to distal fracture fixation by each follow up 
period and treatment arm (complete case) 
 K-Wire 
n =141 
Locking-plate 
n =137 
 
Difference 
 
 Mean Usage (SD) Mean Usage (SD) P-value of t test 
Subsequent Inpatient Care    
Orthopaedics (wrist, arm, other bones) 0.383 (1.252) 0.343 (1.320) 0.796 
Rehabilitation unit 0.007 (0.084) 0 (0) 0.325 
Other surgery 0.170 (0.845) 0.117 (0.385) 0.500 
Outpatient care    
Orthopaedics 3.340 (4.063) 3.788 (4.633) 0.392 
Pathology 0.298 (1.423) 0.358 (1.464) 0.730 
Radiology 1.801 (2.723) 2.197 (2.695) 0.225 
Physiotherapy 6.128 (8.255) 7.584 (11.212) 0.218 
Primary and community care    
In surgery    
GPs 0.766 (2.144) 0.555 (1.212) 0.315 
Practice Nurse 0.113 (0.549) 0.080 (0.322) 0.541 
Physiotherapist 0.879 (2.126) 0.854 (4.420) 0.951 
Occupational therapist 0.071 (0.408) 0.088 (1.025) 0.858 
In clinic    
GPs 0 0.029 (0.241) 0.151 
Practice Nurse 0 0.007 (0.085) 0.311 
District nurse 0 0  
Physiotherapist 0.241 (0.940) 0.409 (2.102) 0.389 
Occupational therapist 0.014 (0.168) 0.051 (0.426) 0.340 
At home    
Practice Nurse 0.007 (0.084) 0 0.325 
Physiotherapist 0.014 (0.168) 0 0.325 
Occupational therapist 0.071 (0.842) 0 0.325 
Aids and adaptation    
Wrist brace/splint 0.780 (1.076) 0.964 (1.239) 0.188 
Grab rail 0.078 (0.464) 0.029 (0.270) 0.286 
Dressing aids 0.071 (0.425) 0.109 (0.649) 0.557 
Long-handle shoe horns 0.014 (0.168) 0.007 (0.085) 0.669 
Bathing aids 0.021 (0.145) 0 0.087 
Kitchen aids (jar/tin openers etc) 0.078 (0.687) 0.066 (0.406) 0.856 
Medications    
ADCAL  0.028 (0.205) 0.007 (0.085) 0.267 
ADCAL-D3 1500 mg 0.064 (0.418) 0.058 (0.482) 0.920 
Acupan    30 mg 0.007 (0.084) 0 0.325 
Alendronic Acid 10 mg 0.043 (0.235) 0.022 (0.147) 0.382 
Alendronic Acid 70 mg 0.220 (1.043) 0.0451 (0.390) 0.077 
Amitriptyline 10 mg 0.064 (0.600) 0.058 (0.683) 0.944 
Amitriptyline 25 mg 0 0.029 (0.241) 0.151 
Amoxicillin  250 mg 0 0.022 (0.256) 0.311 
Aspirin 75 mg 0.028 (0.337) 0.073 (0.703) 0.499 
Atenolol 100 mg 0 0.029 (0.342) 0.311 
Atorvastatin 10 ml 0.028 (0.337) 0 0.325 
Bendroflumethiazide 2.5 mg 0 0.657 (7.689) 0.311 
Bisoprolol 5 mg 0.028 (0.337) 0 0.325 
Cacit  0 0.007 (0.085) 0.311 
Calcium Carbonate Chewable  0.028 (0.205) 0.015 (0.171) 0.544 
Calceos  0.043 (0.376) 0.036 (0.307) 0.883 
35 
 
 K-Wire 
n =141 
Locking-plate 
n =137 
 
Difference 
 
 Mean Usage (SD) Mean Usage (SD) P-value of t test 
Calcichew  0.035 (0.421) 0.066 (0.571) 0.615 
Calfovit D3  0.007 (0.084) 0 0.325 
Citalopram 10 mg 0.028 (0.337) 0 0.325 
Clarithramycin 250 mg 0.007 (0.084) 0 0.325 
Co-Amoxiclan 250 mg 0 0.022 (0.256) 0.311 
Co-Dyramol 500 mg 0 0.044 (0.361) 0.151 
Co-codamol (tab) 30 mg 0.142 (0.661) 0.095 (0.541) 0.518 
Codeine (tab) 30 mg 0.652 (3.408) 0.234 (1.208) 0.176 
Diclofenac 50 mg 0.043 (0.313) 0.051 (0.390) 0.840 
Dihydrocodeine 60 mg 0.121 (1.143) 0.095 (1.111) 0.850 
Enalapril Maleate 10 mg 0.007 (0.084) 0 0.325 
Ergocalciferol 1.25 mg 0.007 (0.084) 0 0.325 
Eye Drops  0.128 (1.516) 0 0.325 
Ferrous Sulphate  0 1.02 (0.851) 0.155 
Floxacillin 250 mg 0.794 (9.432) 0 0.325 
Flucloxacillin 500 mg 0.014 (0.168) 0.015 (0.171) 0.984 
Fultium  0.014 (0.168) 0 0.325 
Furosemide 20 mg 0.028 (0.337) 0 0.325 
Ibruprofen  200 mg 0.092 (0.477) 0.102 (0.633) 0.882 
Ibruprofen 400 mg 0.007 (0.084) 0.022 (0.190) 0.400 
Ibuprofen (gel) 50 g 0.007 (0.084) 0 0.325 
Lactulose 300 ml 0 1.314 (15.378) 0.311 
Lansoprazol 15 mg 0 0.029 (0.342) 0.311 
Lercanidipine  10 mg 0 0.029 (0.342) 0.311 
Livial 2.5 mg 0.043 (0.505) 0 0.311 
Meloxicam (tab) 15 mg 0 0.022 (0.256) 0.311 
Mirtazapine 15 mg 0.014 (0.168) 0.029 (0.342) 0.641 
Meptid 200 mg 0 0.007 (0.085) 0.311 
Morphine 10 mg 0.397 (4.716) 0.044 (0.513) 0.384 
Naproxen  250 mg 0.014 (0.168) 0.015 (0.171) 0.984 
Naproxen  500 mg 0 0.015 (0.171) 0.311 
Nextum 40 mg 0 0.029 (0.342) 0.311 
Nefopam 30 mg 0 0.015 (0.171) 0.311 
Olanzapine 2.5 mg 0 0.029 (0.342) 0.311 
Omeprazole 10 mg 0.007 (0.084) 0.029 (0.342) 0.457 
Omeprazole 20 mg 0.035 (0.347) 0.029 (0.342) 0.880 
Oramorph 10 mg 0 0.007 (0.085) 0.311 
Oxycodone 5 ml 0 0.007 (0.085) 0.311 
Oxycontin 20 mg 0.028 (0.337) 0 0.325 
Oxycontin 30 mg 0.028 (0.337) 0 0.325 
Paracetamol (tab) 500 mg 2.702 (10.11) 1.285 (4.618) 0.136 
Polyfax 4 g 0.298 (3.537) 0 0.325 
Protelos 2 g 0 0.029 (0.342) 0.311 
Risedeonate 35 mg 0.028 (0.337) 0.058 (0.482) 0.546 
Romipril (cap) 10 mg 0 0.029 (0.240) 0.311 
Solphadol  0 0.022 (0.256) 0.311 
Tomoxifen  10 mg 0 0.022 (0.180) 0.311 
Tramadol 50 mg 0.262 (1.850) 0.212 (1.160) 0.785 
Voltrol  25 mg 0 0.029 (0.208) 0.097 
Zopiclone  0 0.007 (0.085) 0.311 
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